AQR Capital Management LLC grew its stake in Global Medical REIT Inc. (NYSE:GMRE) by 48.8% in the 3rd quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 19,836 shares of the company’s stock after acquiring an additional 6,509 shares during the period. AQR Capital Management LLC’s holdings in Global Medical REIT were worth $268,000 at the end of the most recent quarter.
Several other large investors also recently added to or reduced their stakes in GMRE. Winslow Evans & Crocker Inc. bought a new position in shares of Global Medical REIT in the third quarter worth $38,000. Great West Life Assurance Co. Can raised its position in Global Medical REIT by 18.6% during the 3rd quarter. Great West Life Assurance Co. Can now owns 9,470 shares of the company’s stock worth $144,000 after purchasing an additional 1,488 shares during the last quarter. BNP Paribas Arbitrage SA lifted its holdings in Global Medical REIT by 496.8% during the 3rd quarter. BNP Paribas Arbitrage SA now owns 9,590 shares of the company’s stock worth $129,000 after buying an additional 7,983 shares during the period. C M Bidwell & Associates Ltd. bought a new position in shares of Global Medical REIT during the third quarter worth about $162,000. Finally, Squarepoint Ops LLC bought a new stake in Global Medical REIT in the third quarter valued at approximately $181,000. 58.31% of the stock is currently owned by institutional investors and hedge funds.
NYSE:GMRE opened at $13.06 on Friday. The company has a market capitalization of $629.34 million, a P/E ratio of -81.63 and a beta of 0.74. Global Medical REIT Inc. has a 1 year low of $6.98 and a 1 year high of $15.95. The company has a debt-to-equity ratio of 1.23, a current ratio of 0.10 and a quick ratio of 0.10. The business has a fifty day simple moving average of $13.92 and a two-hundred day simple moving average of $13.03.
Global Medical REIT (NYSE:GMRE) last announced its quarterly earnings results on Wednesday, November 4th. The company reported ($0.22) earnings per share for the quarter, missing the Thomson Reuters’ consensus estimate of $0.21 by ($0.43). Global Medical REIT had a negative net margin of 6.11% and a negative return on equity of 1.46%. As a group, analysts anticipate that Global Medical REIT Inc. will post 0.86 earnings per share for the current year.
The company also recently declared a quarterly dividend, which will be paid on Monday, January 11th. Shareholders of record on Monday, December 28th will be paid a dividend of $0.20 per share. This represents a $0.80 annualized dividend and a yield of 6.13%. The ex-dividend date of this dividend is Thursday, December 24th. Global Medical REIT’s dividend payout ratio (DPR) is currently 106.67%.
A number of equities analysts have issued reports on the company. BidaskClub cut Global Medical REIT from a “buy” rating to a “hold” rating in a report on Monday, December 28th. Zacks Investment Research raised Global Medical REIT from a “hold” rating to a “buy” rating and set a $15.00 price objective for the company in a research note on Monday, November 30th. Two analysts have rated the stock with a hold rating and seven have issued a buy rating to the stock. The company presently has a consensus rating of “Buy” and an average target price of $14.64.
Global Medical REIT Company Profile
Global Medical REIT Inc is net-lease medical office REIT that acquires purpose-built specialized healthcare facilities and leases those facilities to strong healthcare systems and physician groups with leading market share.
Read More: Backdoor Roth IRA Conversion and Strategy
Want to see what other hedge funds are holding GMRE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Global Medical REIT Inc. (NYSE:GMRE).
Receive News & Ratings for Global Medical REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Global Medical REIT and related companies with MarketBeat.com's FREE daily email newsletter.